These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3155930)

  • 1. [Chemotherapy of pancreatic cancer].
    Yoshimori M; Tajiri H; Nakamura K; Ozaki H
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):227-34. PubMed ID: 3155930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy for advanced pancreatic carcinoma].
    Yokoyama T; Shimada Y
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2338-43. PubMed ID: 1463339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of cancer of the exocrine pancreas].
    Bonneterre J
    Bull Cancer; 1990; 77(3):267-74. PubMed ID: 2140281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery].
    Kunitomo K; Kawahito M; Miura M; Komi N
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1342-4. PubMed ID: 2437863
    [No Abstract]   [Full Text] [Related]  

  • 5. FAM chemotherapy +/- aminoglutethimide in the treatment of pancreatic carcinoma.
    Lipton A; Harvey HA; Santen RJ; Stryker JA; Barnes SG; Walker BK; Dixon RH; Givant EM; Bartholomew MJ; Nadjafi C
    Eur J Surg Oncol; 1990 Feb; 16(1):12-4. PubMed ID: 2307239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term arterial infusion chemotherapy in unresectable pancreatic cancer].
    Kakizaki K; Yamauchi H; Takahashi N; Kikuti H; Asamura M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2740-2. PubMed ID: 2506819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of adriamycin, mitomycin-C, and tegafur (AMF) chemotherapy on advanced lung cancer].
    Nabeshima K; Iwahashi N; Fujii J; Tamura S; Hada T; Higashino K
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1487-90. PubMed ID: 2990352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of pancreatic cancer is not yet generally recommended].
    Hartwich G
    Med Klin; 1980 Aug; 75(16):575-9. PubMed ID: 6447832
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
    Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK
    Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of implantable drug delivery system (Port-A-Cath) in cancer chemotherapy].
    Okawa T; Kita M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2659-63. PubMed ID: 3415263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced measurable or evaluable pancreatic carcinoma with 17-1A murine monoclonal antibody alone or in combination with 5-fluorouracil, adriamycin and mitomycin (FAM).
    Paul AR; Engstrom PF; Weiner LM; Steplewski Z; Koprowski H
    Hybridoma; 1986 Jul; 5 Suppl 1():S171-4. PubMed ID: 3527946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [UFTM therapy in patients with unresectable pancreatic cancer].
    Uchida Y; Yamaoka K; Kisu T; Mori H; Muto Y
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3151-4. PubMed ID: 3118817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of factors affecting clinical cancer chemotherapy].
    Wakui A; Taguchi T
    Gan No Rinsho; 1983 Aug; 29(10):1199-204. PubMed ID: 6415312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
    Kouvaraki MA; Ajani JA; Hoff P; Wolff R; Evans DB; Lozano R; Yao JC
    J Clin Oncol; 2004 Dec; 22(23):4762-71. PubMed ID: 15570077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
    Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
    Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intra-arterial continuous infusion in patients with advanced and recurrent cancer of the digestive system].
    Kinami Y; Takashima S; Tanaka T; Arizuka S; Ashida Y; Miyazaki I
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1990-8. PubMed ID: 3931561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on the effect of chemotherapy in the treatment of pancreatic cancer].
    Yamamoto M; Saitoh Y; Ohyanagi H; Ishida T; Shimada Y; Tagashira Y; Fujimoto T; Kurogoh F; Okumura S; Uchida K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):703-7. PubMed ID: 3128183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
    Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
    Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.